Company
NYSE:AGN
Allergan is a global specialty pharmaceutical company, which develops and commercialises products for eye care, neuromodulator, skin care and other specialty markets. Its products are sold in over 100 countries worldwide and include the successful and popular Botox and Botox cosmetics treatments.
90 stories · page 4 of 5
US small-cap stocks swing higher after a surprise drop in US weekly oil inventories boosts energy futures and calm jitters over minutes of the Federal Reserve's recent rate-setting meeting
Neither Pfizer or Allergan showed any ill effects from the collapse of the proposed merger
Neither Pfizer or Allergan showed any ill effects from the collapse of the proposed merger
Not for the first time has the ambitious and acquisitive pharmaceutical behemoth Pfizer has been upset at the merger altar, but with its Allergan deal under threat, the company may well step back and assess shareholder value
The combined group will become the world’s largest drug company.
All of the three benchmark indexes are in negative territory.
Below are the main news driven share price changes at 11:02 a.m. in New York on Wednesday:
Wall Street shares are set to rise again in a busy day ahead for earnings and as the global car market is once again under scrutiny.
Deals on Monday took this year's M&A total above 2014
Irish based botox maker Allergan and US drugs giant Pfizer confirmed they are in merger talks.
Archive
The preliminary gross domestic product (GDP) number came in a bit weaker than expected.
A half-hearted rally was under way in the lunchtime trading session,
Below are the main news driven share price changes at 12:04 p.m. in New York on Thursday:
A potential merger would create the world’s largest drug maker.
There is much to think about this morning with the prospect of a 2015 rate hike back on the table and GDP a bit weaker than expected
The Fed went off-piste as far as the market was concerned with its comments yesterday following the interest rate decision
U.S. stocks slumped today, with equities headed for their longest losing streak since January, following the sharpest drop in Chinese stocks in eight years, on worries cooling growth in the world's second-largest economy would hurt it
U.S. stock-index futures fell today after a steep drop in Chinese stocks weighed on markets around the world and as investors wait for the outcome of this week's meeting of the U.S. Federal Reserve. S&P 500 futures were last down 0.5 pe
Teva Pharmaceutical Industries (NYSE:TEVA), an Israeli drugmaker, agreed to buy Dublin-based Allergan PLC's (NYSE:AGN) generic pharmaceuticals business for $40.5 billion in cash and stock, and dropped its hostile offer for Mylan (NASDAQ:MYL
